PMID- 32376334 OWN - NLM STAT- MEDLINE DCOM- 20210427 LR - 20210427 IS - 1097-6779 (Electronic) IS - 0016-5107 (Linking) VI - 92 IP - 5 DP - 2020 Nov TI - Endoscopic endgame for obstructive pancreatopathy: outcomes of anterograde EUS-guided pancreatic duct drainage. A dual-center study. PG - 1055-1066 LID - S0016-5107(20)34261-9 [pii] LID - 10.1016/j.gie.2020.04.061 [doi] AB - BACKGROUND AND AIMS: Anterograde endoscopic ultrasound-guided pancreatic duct drainage (EUS-PDD) refers to transmural drainage of the main pancreatic duct via an endoprosthesis passed anterograde through the gastric (or intestinal) wall. Anterograde EUS-PDD is a rescue procedure for recalcitrant cases of benign obstructive pancreatopathy. METHODS: We conducted a dual-center retrospective chart review of 28 patients (mean age, 59 years; 50% female) who underwent attempted anterograde EUS-PDD between April 2016 and September 2019 for chronic pancreatitis (CP) (93%) or pancreaticojejunostomy stenosis (PJS) after Whipple resection (7%). The study endpoint was achievement of transpapillary/transanastomotic drainage (definitive therapy). RESULTS: Gastropancreaticoenterostomy (ring drainage, definitive therapy) was successfully performed during the index procedure in the 2 patients with PJS (technical success, 100%). Clinical success was 100% in the 2 ring drainage recipients during a mean 18-month follow-up period. The remaining 26 patients with CP underwent attempted pancreaticogastrostomy (PG) with 81% technical success, 75% clinical success, and 15% adverse events (AEs). Repeat endoscopic transmural interventions were performed in the 15 patients with clinical success after PG creation. Definitive therapy transpired in all 15 patients after a median 1 repeat procedure per patient. Clinical success after definitive therapy was maintained in all 15 patients (100%) during a median 4.5-month follow-up. CONCLUSIONS: In agreement with previous studies, our study showed mild to moderately high rates of technical failure (19%), clinical failure (25%), and AEs (15%) during index drainage (PG creation). Among patients with CP with both technical and clinical success after index PG creation (n = 15), 100% definitive therapy was achieved and clinical outcomes were excellent (100% clinical success, 0% AEs). CI - Copyright (c) 2020 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved. FAU - Krafft, Matthew R AU - Krafft MR AD - Section of Gastroenterology and Hepatology, West Virginia University Medicine, Morgantown, West Virginia, USA. FAU - Croglio, Michael P AU - Croglio MP AD - Division of Gastroenterology and Hepatology, University of North Carolina Medical Center, Chapel Hill, North Carolina, USA. FAU - James, Theodore W AU - James TW AD - Division of Gastroenterology and Hepatology, University of North Carolina Medical Center, Chapel Hill, North Carolina, USA. FAU - Baron, Todd H AU - Baron TH AD - Division of Gastroenterology and Hepatology, University of North Carolina Medical Center, Chapel Hill, North Carolina, USA. FAU - Nasr, John Y AU - Nasr JY AD - Section of Gastroenterology and Hepatology, West Virginia University Medicine, Morgantown, West Virginia, USA. LA - eng PT - Journal Article DEP - 20200504 PL - United States TA - Gastrointest Endosc JT - Gastrointestinal endoscopy JID - 0010505 SB - IM CIN - Gastrointest Endosc. 2020 Nov;92(5):1067-1069. PMID: 33160488 MH - *Drainage MH - *Endosonography MH - Female MH - Humans MH - Male MH - Middle Aged MH - Pancreatic Ducts/diagnostic imaging/surgery MH - Retrospective Studies MH - Stents MH - Treatment Outcome EDAT- 2020/05/08 06:00 MHDA- 2021/04/28 06:00 CRDT- 2020/05/08 06:00 PHST- 2019/11/05 00:00 [received] PHST- 2020/04/15 00:00 [accepted] PHST- 2020/05/08 06:00 [pubmed] PHST- 2021/04/28 06:00 [medline] PHST- 2020/05/08 06:00 [entrez] AID - S0016-5107(20)34261-9 [pii] AID - 10.1016/j.gie.2020.04.061 [doi] PST - ppublish SO - Gastrointest Endosc. 2020 Nov;92(5):1055-1066. doi: 10.1016/j.gie.2020.04.061. Epub 2020 May 4.